We describe a set of criteria to evaluate the quality of data and interpretations in chemical interaction studies. These criteria reflect the consensus of the literature on interaction analysis developed over decades of research in pharmacology, toxicology, and biometry; address common pitfalls in published interaction studies; and can be easily applied to common methods of interaction analysis. The criteria apply broadly to interaction data for drugs, pesticides, industrial chemicals, food additives, and natural products and are intended to assist risk assessors who must evaluate interaction studies for use in component-based mixture risk assessments. The criteria may also assist researchers interested in conducting interaction studies to inform mixture risk assessment. The criteria are also intended to serve larger scientific goals, including increasing the repeatability of results obtained in chemical interaction studies, enhancing the reliability of conclusions drawn from interaction data, providing greater consistency of interpretations among various analysts, and decreasing uncertainty in using interaction data in risk assessments. We describe the basis for each criterion and demonstrate their utility by using them to evaluate interaction studies from the recent toxicological and pharmacological literature, which serve as examples of different types of data sets that the risk assessor may encounter.
I. INTRODUCTION AND BACKGROUND
For a number of years, the scientific and regulatory communities have expressed concern that risk assessments for synthetic chemicals fail to adequately address the toxicity of chemical mixtures found in products, food, and the environment. Recently, this concern has intensified. The Food Quality Protection Act of 1996 emphasized chemical mixtures by requiring assessments of cumulative risks (Fed. Reg. 1998a, b) . In 1997, the Presidential Commission on Risk Assessment and Risk Management (CRARM 1997) recommended moving beyond risk assessments for individual chemicals to a broader focus on the toxicity of chemical mixtures. In 1998, the U.S. Environmental Protection Agency's (USEPA) Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) recommended screening six specific chemical mixtures (EDSTAC 1998) . The USEPA has for many years focused attention on chemical mixtures in the risk assessment process (USEPA 1989a) including the recommendation of Toxic Equivalency Factors for dioxins and dibenzofurans (USEPA 1986) . More recently, the USEPA supplemented its 1986 mixture risk guidelines (USEPA 1986) and Technical Support Document (USEPA 1990 ) with a draft Guidance Document on health risk assessment of chemical mixtures (USEPA 1999) . The USEPA's approach to risk assessment for chemical mixtures begins with an evaluation of data quality to determine the adequacy of (1) exposure data for the mixture; (2) information on health effects of the mixture; and (3) information on interactions between components of the mixture. In this paper, our interest is in evaluating studies that provide the third type of information, interactions between mixture components.
In this paper we describe a set of criteria to evaluate the quality of data and interpretations in toxicological interaction studies. These criteria may assist risk assessors in identifying studies that can be used in component-based mixture risk assessments as well as those studies that are less useful due to inadequacies in design or interpretation (a component-based approach is used when obtaining data on the whole mixture is impractical). The criteria also may be used in applying a weightof-evidence approach to interaction studies that reach contradictory conclusions regarding whether or what types of interactions occur.
To be meaningful, criteria for evaluating interaction studies should be based on accepted methods of analysis, address common pitfalls, and be easily applicable to methods typically used in interaction studies. Kortenkamp and Altenburger noted that methods for analyzing interactions have been developed over the last 100 years in the fields of pharmacology, toxicology, ecotoxicology, epidemiology, chemotherapy, and biometry (Kortenkamp and Altenburger 1998) . Indeed, the scientific literature contains many publications describing methods for conducting interaction studies. Some examples that provide methodological background include: (Berenbaum 1978 (Berenbaum , 1981 (Berenbaum , 1984 (Berenbaum , 1985 (Berenbaum , 1989 Carter et al. 1979; Carter et al. 1984; Carter and Wampler 1986; Caudle and Williams 1993; Chou and Talalay 1984; Gennings 1995 Gennings , 1996 Gennings et al. 1990; Gessner 1995; Greco et al. 1995; Greco et al. 1990; Loewe and Muischnek 1926; Machado and Robinson 1994; Martinez-Irujo et al. 1996; Poch 1980a,b; Poch et al.1990a; Poch and Holzmann 1980; Londong 1985, 1993; Poch and Pancheva 1995; Poch et al. 1995a.; Poch et al. 1990; Poch et al.1990b; Scaramellini et al. 1997; Suhnel 1990 Suhnel , 1996  200350.pgs 4/13/01, 2:31 PM
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Tallarida 1992; Tallarida et al. 1989; Tallarida and Raffa 1996) . The scientific literature also contains many recent studies that claim to have demonstrated interactions between chemicals, some examples of which include: (Abdelghani et al. 1997; Abou-Donia et al. 1985; Arnold et al. 1996a Arnold et al. , 1996b Arnold et al. , 1997a Banks and Soliman 1997; Baynes et al. 1997; Ben-Shlomo et al. 1993; Bianchi et al. 1994; Bianchi-Santamaria et al. 1997; Bouakka et al. 1988; Brown 1997; Christ et al.1990; Cohen et al. 1972; Cohen and Murphy 1971; Dent and Orrock 1997; Dorian et al. 1983; Fletcher et al. 1995; Garfield and Bukusoglu 1996; Groten et al. 1996; Holzmann et al. 1992; Howe et al. 1998; Hu et al. 1987; Jaworska et al. 1997; Kissin et al. 1990 Kissin et al. , 1992 Kissin et al. 1987; Kissin et al. 1989 Kissin et al. , 1991 Kreitzer and Spann 1973; Lau and Wang 1996; Le et al. 1997; Levasseur et al. 1997; Livingston and Dethlefsen 1979; Lu et al. 1997; Marinovich et al. 1994; Marinovich et al., 1996; Martin et al. 1997; Mayer and Doolittle 1995; McCain et al. 1997; McLachlan 1997; Misslin et al. 1988; Monette et al. 1997; Naguib and Abdulatif 1993; Piatti et al. 1994; Porter et al. 1993; Proudfoot et al. 1997; Qureshi et al. 1992; Rajamoorthi et al. 1997; Ramakrishna and Ramachandran 1978; Recker and Kier 1997; Redai et al. 1995; Ribas et al. 1997; Riekkinen et al. 1997; Sanders et al.1993; Shou et al. 1994; Siegmund et al. 1992; Siller et al. 1997; Soto et al. 1994; Stinecipher and Shah 1997; Sumpter and Jobling 1995; Takahashi et al. 1987; Taylor et al. 1995; Thompson and Moerschbaecher 1982; Tverskoy et al. 1989; Vale et al. 1997; van Birgelen et al. 1994a van Birgelen et al. ,b, 1996 van Steveninck et al. 1993; Verma et al. 1997; Verschoyle et al. 1982; Vonier et al. 1996; Wessinger and Balster 1987; Yu et al. 1997) .
Meaningful criteria should also serve larger scientific goals. The criteria should help researchers generate data that are more interpretable, interpretations that are more consistent with the data, and hypotheses that are more testable. Application of the criteria should also promote consistency of interpretation among various analysts viewing the same data. The criteria should provide a basis for better understanding differences between studies and methods of analysis, and should also facilitate understanding the differences between various analysts with respect to their assumptions and conclusions. Application of the criteria should ultimately lead to better risk assessments because the relative strengths of published studies may be understood in the context of the goals of the risk assessment, and because uncertainties can be better quantified according to a replicable standard of measure. The value of the criteria presented here could be judged by the degree to which they further such goals.
The following set of criteria for evaluating interaction studies are based on our evaluation of the literature and reanalysis of the data reported in a number of published studies: Criterion 1. Dose response curves (DRCs) for the mixture components should be adequately characterized.
Criterion 2.
An appropriate "no-interaction" hypothesis should be explicitly stated and used as the basis for assessing synergy and antagonism.
Criterion 3.
Combinations of mixture components should be assessed across a sufficient range to support the goals of the study.
Criterion 4. Formal statistical tests should be used to distinguish whether the response produced by a dose combination is different (larger or smaller) from that predicted by the "no-interaction" hypothesis.
Criterion 5.
Interactions should be assessed at relevant levels of biological organization.
The five criteria proposed here do not attempt to address every issue pertaining to the use of interaction data in risk assessment. The criteria assume that assays and assumptions employed in interaction studies also satisfy standards of minimal epistemic status (i.e., issues pertaining to the quality of the data themselves as opposed to inferences drawn from the data). For example, the criteria do not stipulate but rather assume that assays used in interaction studies be valid for measuring the intended biological endpoint. The criteria do, however, address issues of data quality regarding statistical tests specific to interaction analysis (Criterion 4). Several of the criteria address the quality of inferences drawn from interaction experiments rather than the quality of the data themselves (Criteria 1-3, 5). Nonetheless, the criteria leave unapprised many of the scientific judgements that must be applied when choosing among various biological models or choosing between models of noninteraction for performing a study. Our intent here is to provide criteria that are specific to interaction analysis and that will assist the evaluation and comparison of interaction studies, but that do not bias the assessor toward specific approaches.
Satisfying these criteria may not render the results of an interaction study suitable for every purpose or every risk assessment. Nevertheless, the literature appears to express a consensus that these criteria are the minimum standards for testing chemical interactions and reliably interpreting the dose response data. As such, these criteria can be applied broadly to interaction studies for drugs, pesticides, industrial chemicals, food additives, and natural products. The degree to which a particular study fulfills each criterion must be judged in the context of the goals of the study and the interpretations drawn from the data. Whether or not the results of a study should be used in risk assessment must be judged by the relevance of the study to the exposure scenario of interest, the degree to which the study satisfies the set of five criteria, and the level of uncertainty acceptable in the risk estimate.
The remainder of this article is divided into three sections. Section II describes the foundation of the criteria in detail, using formulae and examples where needed. Section III provides examples of how the criteria can be applied to studies from the scientific literature and can help identify common deficiencies. Section III is divided into four subsections: (A) identifying studies that satisfy all five criteria; (B) using the criteria to weight contradictory data; (C) using the criteria to uncover inadequacies in studies; and (D) using the criteria as a design tool to improve study reliability. In Section IV, we discuss how the criteria advance larger scientific goals and offer a few concluding remarks.
II. EXPLANATION AND DISCUSSION OF THE CRITERIA
Before describing the criteria in detail, a brief discussion of key terminology is in order. "No-interaction hypothesis" refers to the testable proposition that the effect Evaluative Criteria for Interaction Studies of chemicals in combination conforms to an appropriate non-interaction model. "Non-interaction model" refers to a mathematical function for predicting the level of response produced by any dose combination assuming that the individual components do not interact in producing a biological response. "Dose combination" refers to simultaneous treatment with specific amounts of two different agents, and a "fixed mixture" refers to a constant ratio of the mixture components across a range of concentrations. "Combination response" refers to the observed response produced by the dose combination, and a "non-interactive response" is a combination response that conforms to a non-interaction model. "Synergism" or "antagonism" refer to combination responses greater than or less than the responses predicted by the non-interaction model.
Criterion 1.
Dose response curves (DRCs) for the mixture components should be adequately characterized.
The need to characterize the dose response curves (DRCs) of the individual chemical components of a mixture is stressed widely in the literature (Berenbaum 1981 (Berenbaum , 1989 Calabrese 1991; Groten et al. 1996; Merlin 1994; Suhnel 1990 ). Without adequate DRC characterization for the individual components, it is not possible to determine whether a biological effect of a mixture is due to interactions between the components. As such, Criterion 1 assists in evaluating the quality of inferences drawn from an interaction study rather than the quality of the data themselves.
Ideally, dose response characterization for the individual components should be sufficient to determine slope, inflection points, maximal and minimal response levels, 1 and should include the dose range corresponding to the dose combinations to be tested. Various dose response models may be employed to represent observed data, including the probit or logit. Greco and co-workers suggest the three-parameter Hill model (Greco et al. 1995; Hill 1910) , which has the ability to accommodate a broad range of dose response data, but more recently have used the four-parameter Hill model, which includes an additional background parameter for residual effects of inhibitory agents at very high concentrations (Faessel et al. 1998; Levasseur et al. 1997) . Mathematical transformations of the response measurement that result in a linear relationship between transformed response and dose greatly simplify the interaction analysis. In some dose ranges, simple linear interpolation may replace more complex mathematical dose response models for characterizing the dose response relationship used to assess interactive effects.
The significance of this criterion can be illustrated by considering a theoretical interaction experiment using two doses of a single chemical rather than doses of different chemicals. The dose response relationship for this single chemical is sigmoidal as depicted by the bold sigmoid-shaped curve in Figure 1 . Rather than characterizing the DRC through its full range, this theoretical interaction experiment employs only two doses of the chemical, D1 and D2. The measured effects at 1 The response measurement may be continuous (i.e., the concentration of another chemical), binary (i.e., the rate of sex reversal in individuals), or otherwise discrete (i.e., ordered categories for severity), so long as the observations yield some quantitative result.
Figure 1.
Illustration of how inadequate dose-response characterization could lead to the erroneous conclusion that two doses of a single chemical synergize. The measured effects at D1 and D2 are denoted by E1 and E2 respectively, and the measured effect at zero dose (control) is zero. Although E1 and E2 lie on the actual dose-response curve of the chemical, in the absence of other data points along the true curve, they define an artificially linear dose-response relationship (line Z). The predicted effects of combined doses D1 + D2 (D3) and D2 + D2 (D4) are EZ3 and EZ4, respectively. However, because the true dose-response curve is sigmoidal, the observed effects produced by the combinations D1 + D2 and D2 + D2 will be E3 and E4, respectively, rather than EZ3 and EZ4 as predicted by line Z.
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D1 and D2 are denoted by E1 and E2, respectively, and the measured effect at zero dose (control) is zero. Although E1 and E2 lie on the actual DRC of the chemical, in the absence of other data points along the true curve, they define an artificially linear dose response relationship (line Z in Figure 1 ). Based on the dose response relationship described by line Z, the predicted effects of dose combinations D1 + D2 and D2 + D2 are EZ3 and EZ4, respectively. Because the true DRC of this chemical is sigmoidal, however, the observed effects produced by the combinations D1 + D2 and D2 + D2 will be E3 and E4, respectively, rather than EZ3 and EZ4 as predicted by line Z (Figure 1) . Comparison of the observed versus predicted effects would lead to the erroneous conclusion that both dose combinations D1 + D2 and D2 + D2 for this single chemical were synergistic (i.e. the responses E3 and E4 were greater than expected) when in fact, they are precisely as would have been expected (i.e., dose additive) if the full DRC had been characterized. Inadequate dose response characterization could therefore lead one to conclude that two doses of a single chemical synergize when mixed. Without adequate DRC characterization, erroneous conclusions might be compounded greatly for mixtures of chemicals with differently shaped DRCs.
Criterion 2.
Interactions are inferred when a mixture of chemicals produces a biological response greater or less than expected based on mathematical concepts of noninteraction (Berenbaum, 1981 (Berenbaum, , 1989 Boyd et al. 1990; Greco et al. 1995; Loewe and Muischnek 1926; Machado and Robinson 1994; Suhnel 1990; Unkelbach 1992 ). Thus, a "no-interaction hypothesis" must be defined that predicts the level of response expected if chemicals do not interact. Use of this concept allows the interactive effects of agents in combination to be assessed according to classical modes of hypothesis testing. A combination response that does not conform to the chosen no-interaction hypothesis is an indication of interaction, i.e., the measured response deviates from the response predicted by the non-interaction model. Synergy is inferred if the measured response resulting from the mixture exceeds the response predicted under the no-interaction hypothesis; antagonism is inferred if the measured response is less than predicted under the no-interaction hypothesis. Since conclusions regarding chemical interactions must be based on testing an appropriate no-interaction hypothesis, Criterion 2 is used to evaluate the quality of inferences drawn from a study rather than the quality of data obtained.
Two models of non-interaction have been well developed in the pharmacological and toxicological literature and are appropriate as the basis for a no-interaction hypothesis.
2 Loewe additivity (Loewe and Muischnek 1926 ) is based on the concept that an agent cannot interact with itself. Loewe additivity predicts that two noninteracting compounds will behave as dilutions of one another when combined. Expressed mathematically, A/A* + B/B* =1, where A/A* and B/B* are fractions of 2 Greco et al. (1995) provide a comprehensive discussion of the debate over the best reference model for "no-interaction". Greco et al. (1995) propose Loewe additivity as the first choice and Bliss independence as an alternative.
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Loewe additivity would accurately predict additive responses E3 and E4 for dose combinations D1 + D2 and D2 + D2 in Figure 1 , regardless of the form of the DRCs. When the DRCs are linear, a special case of Loewe additivity occurs in which the predicted additive response is simply the sum of the responses. The outcome for this special case is sometimes referred to as "effect" or "response" addition.
The second model of non-interaction is Bliss independence (Bliss 1939 ). Bliss independence is often used as the general definition of "response" additivity, and is equivalent to Loewe additivity only under the special case of DRC linearity. Independent effects of A and B in combination (E A+B ) are calculated from the individual effects (E A and E B ). The Bliss independence model expresses probabilistic independence between the two compounds. Expressed mathematically, E A+B = E A +E B -(E A xE B ), where E is the probability of an effect (e.g., the probability of mortality). Independence implies functional independence between two chemicals such that the incremental effect of one compound is unchanged in the presence of a second (Berenbaum 1981; Poch et al. 1990a Poch et al. ,b, 1995b Unkelbach 1992) . In other words, the body responds to A as if B were not present. Bliss independence has an alternate form for the complement of the effect. For example, if the effect is mortality, the complement is survival. Whereas Bliss independence for mortality is described as E A+B = E A +E B -(E A xE B ), Bliss independence for survival is E( A+B )′ = E A ′xE B ′ = (1-E A )(1-E B ).
Bliss independence can be illustrated by considering the action of two anti-tumor agents. Suppose that a dose of agent A produces 30% cell kill, while a dose of agent B produces 20% cell kill. For cell kill, independence predicts: 20% + 30% -(20% × 30%) = 44%. A response greater or less than 44% would indicate an interaction.
Conversely, a dose of agent A results in 70% cell survival, while a dose of agent B results in an 80% cell survival. For cell survival, the expected combination response E( A+B )' is 70% × 80% = 56%.
The choice of a non-interaction model can influence the interpretation of a study. Greco et al. (1995) describes a sham experiment involving reasonable and adequately characterized DRCs where assuming Bliss independence leads to the paradoxical conclusion that a drug is synergistic with itself. If the DRCs are exponential (e.g., 1-e -βd ), then Loewe additivity and Bliss independence are equivalent (Berenbaum 1989) . For other DRC functional forms, conclusions based on Loewe additivity and Bliss independence, generally, would not be the same (Greco et al. 1995; Poch et al. 1990b) .
Currently, there are no compelling criteria for choosing between the two noninteraction models when designing an interaction study. Simultaneously discerning the "correct" non-interaction model and deviations from that model is a conundrum for which there would appear to be no general solution based upon real data. One approach for choosing the non-interaction model that might be considered is to select the non-interaction model based on the biological mechanism of action of the chemicals. However, considerable mechanistic detail might be required, as demonstrated by Jackson (1993) . Jackson showed that differences in the Vmax of a single enzyme can change the interaction of two inhibitors from synergy to antagonism if one inhibitor interacts with the active site of the enzyme and the other limits 200350 .pgs 4/13/01, 2:31 PMsubstrate availability at the active site. Few toxicological mechanisms are known in such detail. In fact, it is the paucity of information about mechanisms that leads us to an empirical approach for assessing interactive effects. If mechanisms were understood well enough to differentiate between the two non-interaction models, that same understanding could be used to predict the expected outcome for a mixture (Berenbaum 1981; Berenbaum 1989) . Then, an interaction experiment would be a test of mechanistic understanding rather than an empirical test of a nointeraction hypothesis.
If the goal of a study is test interactions rather than to probe mechanistic understanding, then the study cannot be deemed either more or less valid based simply on the no-interaction hypothesis tested. The critical feature we are concerned with in this criterion is that an appropriately defined no-interaction hypothesis is tested and the results of the study interpreted with respect to that particular model. The mixtures literature favors Loewe additivity as the no-interaction model, in part due to paradoxes such as the one described by Greco (see above). In many cases, it may be informative to compare combination responses by both models of non-interaction (Kodell and Pounds 1991; Poch et al. 1990a,b) .
It is important to recognize that the literature is inconsistent in terminology for the two main types of interactions. Although attempts have been made to standardize nomenclature (Greco et al. 1992 (Greco et al. , 1995 Henschler et al. 1996; Unkelbach and Wolf 1984; USEPA 1990 USEPA , 1999 , authors frequently differ in their interpretations and often neglect to define the terms they use. Some authors sub-classify the terms antagonism or synergism (Calabrese 1991; Poch and Londong 1985) , while others use several words synonymously. For example, potentiation often refers to a form of synergy in which one chemical does not produce a measurable response at any dose, but sometimes the term is used simply to mean "greater than additive," i.e., as a general synonym for synergy. Although we recognize that finer classification of terms may be useful for some purposes, we refer only to the two major categories of interactions -synergism and antagonism -because the criteria also apply to their subcategories.
Criterion 3:
To understand the necessity for this criterion, it is important to appreciate that the pharmacological and toxicological characteristics of a mixture are dependent upon the identity of the chemical components, the concentration of the mixture, and the concentration ratio of the components within the mixture. For a given set of chemicals, different mixture concentrations and component ratios can exhibit different types of interactions and biological effects (Berenbaum 1981) . Even a fixed ratio of two chemicals can produce different types of interactions when tested across a broad range of mixture concentrations. Thus, to completely characterize interactions of a mixture requires testing numerous combinations of all mixture components across their full dose response ranges. Only when the goals of the study and the interpretations are more narrowly constrained is it sufficient to test fewer dose ratios across a narrower dose response range. Since it is likely that some dose combinations will interact and others will not (Berenbaum 1981 (Berenbaum , 1989 Greco et al. 200350 .pgs 4/13/01, 2:31 PM 267 1992, 1995; Poch et al. 1990b) , it can be difficult to make global statements about interactions that are applicable to all dose combinations of a mixture. Because of this limitation, it is important to guard against over-interpreting data from studies where the design could, at best, support only narrowly constrained conclusions. Criterion 3 is thus used to evaluate the quality of inferences drawn from a study rather than the quality of data obtained.
The goals of an interaction study should be used to determine the number of different ratios of the individual components and the dose range across which a mixture should be tested, i.e., the dose combination(s) of interest. It is possible for the goals of an interaction study to be more narrowly constrained than providing global characterizations of interactions. For example, Howe et al. (1998) assessed a single dose combination of the herbicides alachlor and atrazine found in a formulated product and appropriately constrained their interaction interpretation to this fixed mixture. Howe's study constitutes a local assessment of interactions that may be meaningful for certain occupational risk assessments. For other types of environmental risk assessments, different dose combinations of alachlor and atrazine may need to be tested because dose combinations found in the environment may differ greatly from the starting material. Not only might chemicals degrade at different rates and have different transport characteristics in the environment, but also interactions that occur when concentrations of the individual chemicals alone are sufficient to produce biological effects may not occur at lower mixture concentrations.
A number of different approaches can be used to study chemical interactions of mixtures (for reviews see Berenbaum 1989; Cassee et al. 1998; Greco et al. 1995) . A full-factorial design tests a full complement of component ratios across the full dose response range of the mixture. Fractional factorial designs reduce the number of tests to a specified subset of mixture combinations while maintaining a substantial proportion of the information that would be produced with a full factorial design. Ray designs test fixed mixtures, i.e., a constant ratio of the mixture components, across a range of concentrations. Berenbaum has described an approach for testing interactions between any number of agents by assessing fixed mixtures comprised of fractions of specific effect concentrations, such as the EC50 concentration (Berenbaum 1978) . Whatever design is employed in a mixture study, it is important that the data set generated is sufficient to allow conclusions that satisfy the goals of the study. Thus, numerous approaches are candidates to fulfill our third criterion providing that the study design and the methods used to evaluate the data support the goals of the study and the interpretations drawn from it.
Criterion 4.
A formal statistical test should be used to distinguish whether the response produced by a dose combination is different from that predicted by the "nointeraction" hypothesis.
Researchers often fail to appropriately test whether the observed response differs from the predicted "no-interaction" response (Berenbaum 1989; USEPA 1990 support an interaction conclusion. In order to support a conclusion, departures from non-interaction that occur within the biological response range of the assay must be detectable at an acceptable level of statistical confidence. Therefore, our criteria for evaluating the quality of interaction studies include the explicit requirement for a statistical test appropriate for interaction analysis. Since the statistical test is an integral component of interaction data, Criterion 4 addresses an issue of data quality and is needed to fulfill a standard of minimal epistemic status for an interaction study.
Statistical analysis may be applied to data from toxicity tests of mixtures in either an exploratory or confirmatory mode. An exploratory analysis can be applied in a pilot investigation to assist the researcher in identifying potential interactions and additional dose combinations to test for confirmation. A confirmatory analysis uses combination responses to establish, with a reasonable level of statistical certainty, an interaction conclusion. A variety of statistical methods have been used to infer whether mixture components interact (e.g., simple t-tests, linear models including ANOVA and multiple regression, and logistic regression). 3 In a confirmatory analysis, sufficient replication is important to assure an acceptable level of statistical power (i.e., the probability of detecting a departure from the "no-interaction" hypothesis if, in fact, the "no interaction" hypothesis is false). Recording statistical power in a research report is particularly important where the result indicates acceptance of the "no-interaction" hypothesis. Statistical power is also important for interpreting the magnitude of the interaction that can be observed, a factor that may influence how the data are used in risk assessment.
The statistical model and assumptions underlying the analysis should not introduce a bias that favors one of the possible outcomes, either interaction or noninteraction. To avoid bias, it is essential to apply statistical methods and statistical tests in a manner that is consistent with a clearly specified no-interaction hypothesis and appropriate model of non-interactive effects. A clear statement defining the response expected if the mixture components do not interact (Criterion 2) underlies all analyses and conclusions of synergism, antagonism, or no-interaction. Without a clearly stated no-interaction hypothesis, the results of any statistical test cannot be interpreted. Statistical confirmation is necessary for inferences concerning both single dose combinations as well as those that are interpreted as global (i.e., for all dose combinations).
Criterion 5.
It is critical to select the proper level or levels of biological organization at which interactions are assessed so that the results can be interpreted meaningfully. Interaction experiments conducted at the level of the whole organism or population can be difficult to interpret without information from underlying levels of biological organization. On the other hand, numerous interactions may be detected at the molecular, biochemical, or cellular level that never manifest change in the organism 3 For an in-depth discussion of the strengths, weaknesses and appropriate use of various approaches see Carter et al. 1988; Gessner 1988; and Greco et al. 1995. 200350 .pgs 4/13/01, 2:31 PM 269 or in populations of organisms. Because such phenomena have been observed repeatedly in the search for drug interactions to improve antibiotic and cancer chemotherapy, pharmacological synergism and antagonsim are not considered to be synonymous with clinical advantage and disadvantage (Berenbaum 1988; Merlin 1994; Wampler et al. 1992) . McInnes and Brodie (1988) have discussed the pitfalls of failing to adequately assess interactions at relevant levels of biological organization. Criterion 5 is intended to help avoid such pitfalls and to assist in evaluating the quality of interpretations drawn from interaction data.
Although predicting effects on organisms or populations of organisms is often the ultimate goal of interaction analyses, interactive effects of chemicals may not be discernable at higher levels of biological organization for a number of reasons. One possible reason is an inability to fully assess DRCs (Criterion 1) or to test a sufficient range of dose combinations (Criterion 3) in particular types of assays at the wholeorganism or population level. A population or community may also be exposed to other unmeasured stressors, or may have high background responses that lower the statistical power of detecting changes in the effect of concern. Another possibility is that a high level of biological organization may respond identically to qualitatively different types of interactions. Complex homeostatic feedback mechanisms and counterbalancing physiological systems not only present the opportunity for interactive effects in whole organisms and populations, but these may also confuse the interaction (or lack thereof) underlying a response.
There are also many reasons that interactions at lower levels of biological organization might never manifest change in an organism or population. Pharmacokinetic behavior in vivo may preclude pharmacodynamic interactions that are detectable in vitro. Interactions at the molecular level may occur in organisms only at concentrations above those that produce toxicity unrelated to the interaction. Chemicals may trigger adaptive or compensatory responses in organisms that abrogate interactions at the cellular or biochemical level.
The fifth criterion is different conceptually and practically from either the obvious requirement to corroborate in vitro results with in vivo effects or the implication that an understanding of mechanism is essential for characterizing interactions. This criterion emphasizes that experiments and observations at multiple levels of biological organization may be necessary to properly characterize interactions that occur in complex biological systems. Each level of biological organization may have limitations for assessing interactions, and such limitations should be minimized by selecting assays at a level (or levels) relevant to the goals of the study. Failure to appreciate limitations in the level of biological organization utilized can lead to errors of interpretation and characterization common in the interaction literature. Carefully discerning the limitations of various approaches can help focus investigative research and toxicity assessments on interactions that have significance to human and ecological health.
Because this criterion may not be readily understood apart from its application, we extend our discussion here by considering theoretical interaction experiments using two classic therapeutic agents, propranolol and epinephrine, as an example. A later discussion in this review (see subsection entitled "Synergistic Pheromone Analogs") also underscores the importance of assessing interactions at relevant levels of biological organization and will assist the reader in understanding and applying the fifth criterion.
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Epinephrine, one of the endogenous autonomic neurotransmitter hormones, is a universal α-β-adrenergic receptor agonist and is also used clinically as a pressor agent. Propranolol is a nonselective β-adrenergic receptor antagonist and the first of such drugs to gain wide clinical use, mainly in the treatment of hypertension. A surprising response has been seen in some patients on propranolol that receive epinephrine during minor surgical procedures. Rather than propranolol blunting the pressor action of epinephrine, some patients have experienced an acute hypertensive crisis (Dzubow 1986; Whelan 1987) .
Interaction experiments performed at suborganismal levels of biological organization might not predict synergism between propranolol and epinephrine. Competitive binding studies and adrenergic functional assays performed in a tissue preparation that contains predominantly α-adrenergic receptors, such as skin, would be expected to show no interaction between propranolol and epinephrine. If the same types of experiments were performed in cardiac muscle, a tissue that contains predominantly β1-adrenergic receptors, propranolol would be expected to displace radiolabeled epinephrine competitively, have no β1-stimulatory activity alone, but to antagonize β1-stimulation by epinephrine. Thus, depending on the tissue and assay, either non-interaction or antagonism might be found.
The reported hypertensive crisis appears to be dose dependent and is thought to be due to unopposed α-pressor activity of epinephrine in the presence of the β-receptor blockade by propranolol (Dzubow 1986) . Epinephrine normally has a bimodal effect on vascular tone, constricting some vessels through α-stimulation and relaxing others through β-stimulation. In the presence of propranolol, only vasoconstriction occurs, which can produce the abnormally large increase in blood pressure. Experiments in whole animals would be necessary to detect a synergism of epinephrine-induced blood pressure elevation because it is the integrated response of different receptor systems and different tissues to these drugs that produces the precipitous rise in blood pressure. On the other hand, the clinical observation of hypertensive crisis in patients receiving combinations of epinephrine and propranolol is initially surprising and gives little clue as to the type of interaction that produces the response.
III. EVALUATING INTERACTION STUDIES USING THE FIVE CRITERIA
In the following section, we attempt to demonstrate the utility of the five criteria for evaluating interaction studies by applying them to a series of publications from the recent toxicological literature. The goal of this section is to show how the risk assessor can use the criteria to evaluate interaction studies when conducting mixture risk assessments. To meet this goal, we apply the criteria to three different types of data sets that the risk assessor may encounter when evaluating interaction studies. We first discuss three studies that differ in goals and in methodology, yet that all fulfill our criteria. These three studies are conducted with sufficient rigor to be used in lieu of default assumptions in a component-based approach to assessing mixture effects. Next, we discuss an example in which the criteria are used to weight two studies that come to contradictory conclusions regarding the interaction between chemicals. Third, we apply the criteria to studies that lack sufficient rigor to be used in lieu of a default additivity assumption for the toxicity of chemicals in mixture. We
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A. Studies That Satisfy All Five Criteria

Kissin et al. (1987)
Kissin and co-workers demonstrated convincingly that the loss of righting reflex in rats administered thiopental is synergized by the opiate agonists morphine and fentanyl. The loss of righting reflex in rats has been used extensively in pharmacology to test the hypnotic effects of drugs (Erickson et al. 1980; Garfield and Bukusoglu 1996; Gessner 1995; Hu et al. 1987; Kissin et al. 1989 Kissin et al. , 1990 Kissin et al. , 1991 Kissin et al. ,1992 Kurtz et al. 1996; Tverskoy et al. 1989) , and is used to predict sedative-hypnotic potency in humans. Although the exact mechanisms that produce loss of the righting reflex are not fully characterized, the results of the assay are directly interpretable with respect to the sedative-hypnotic potency of the dose of drug administered. Thus, Kissin and co-workers tested the interaction at a relevant level of biological organization (Criterion 5).
DRCs were characterized at five dose levels for each drug individually (Criterion 1) and for three different fixed mixtures of the agents (e.g., morphine alone; thiopental alone; thiopental plus morphine at ratios of 1:0.7, 1:3.5, 1:17) (Criterion 3). A similar scheme was used to test combination responses of thiopental and fentanyl. The drugs were tested individually at doses equally spaced across a range from one that blocked the righting reflex in none of the animals to one that blocked in all of the animals (fulfills Criterion 1). Results of the individual dose response experiments were used to determine the dose combinations to be tested (fulfills Criterion 3). A probit procedure was used to determine ED50 values from the DRC of each fixed mixture. ED50 additivity isoboles and ED50 dose combinations for each fixed mixture were plotted on a single isobologram. Since isobolographic techniques are based on Loewe-additivity, the requirements of Criterion 2 are met (see Figures 2 and 3 for an explanation of isobolographic methods).
The distance between the ED50 dose for a fixed mixture and a corresponding reference point on the additivity isobole was used to perform a statistical test (Criterion 4) of the no-interaction hypothesis. The reference point on the additivity isobole was determined by its intersection with a line connecting the origin and the ED50 dose of the fixed mixture. The standard error of this distance was computed by the method of propagation of error (Ku 1966) . Error estimates from a fixed mixture ED50 point as well as from single-drug ED50 points were used. The ratio of the measured distance to its standard error was subjected to an approximate t-test under the null hypothesis of Loewe additivity. Differences from the predicted additive response were found for three ED50 dose combinations of morphinethiopental (p < 0.001). Two ED50 dose combinations of fentanyl-thiopental were also different from the response expected based on Loewe additivity (p < 0.01), and one dose combination was additive (non-significant at p < 0.5). Criterion 4 is thus fulfilled by Kissin et al. (1987) .
The concise study by Kissin and colleagues (Kissin et al. 1987) Illustration of an observed isobologram for theoretical chemicals R and T. Combination doses of R and T isoeffective with individual doses are plotted according to their dose coordinates. Combination doses that conform to the nointeraction hypothesis, i.e., are Loewe additive, fall along the additivity isobole. Synergistic combinations of R and T fall below and antagonistic combinations above the additivity isobole.
200350.pgs 4/13/01, 2:31 PM 276 study (see Table 1 ). The Kissin study is also an example of using an assay with direct relevance to the whole organism to test chemical interactions. Interaction studies are often intended to have relevance to either whole organisms or to populations of organisms. Other levels of biological organization, however, may also be of interest. Sometimes it is the molecular level of biological organization that is relevant because the goals of the study are to understand fundamental modes of toxicity at the molecular level, such as mutagenicity. In other instances, a molecular or cellular level of biological organization is relevant because it can provide information about the mechanism underlying effects observed in organisms or populations. The next study discussed is an example in which the cellular level is the relevant level of biological organization to test interactions between chemotherapeutic agents.
Levasseur et al. (1997)
Synergistic cytotoxicity is of particular interest to pharmacologists working on the development of chemotherapeutic regimens. Synergistic cytotoxicity presents the potential for increased efficacy against disease without increasing toxicity to the patient (Greco et al. 1996) . The combination of paclitaxel and cisplatin shows good clinical efficacy against ovarian carcinoma. The mechanism of this efficacy is not fully understood, but its elucidation could provide clues as to how the therapeutic regimen might be optimized. Levasseur and co-workers studied the growth inhibitory effects of combinations of paclitaxel and cisplatin in various drug-sensitive and drug-resistant human carcinoma cell lines in order to examine a potential cellular basis for the combination efficacy of these agents.
The study was designed to address the following specific questions regarding potential interactions between the agents. Might synergy at the cellular level contribute to the clinical efficacy of paclitaxel and cisplatin? What is the shape of the interaction response surface for paclitaxel and cisplatin for a set of human cell lines and drug exposure schedules? Does drug resistance modify the cellular response to the combination of paclitaxel and cisplatin? These clearly stated goals provided a rational basis for the study design and the type of interaction analysis used. Table 1 summarizes how the Levasseur study fully satisfies all five criteria, but several features of the study are worth discussing in more detail. Levasseur et al. (1997) used a statistical method that not only satisfied Criterion 4 but also allowed them to quantify the magnitude of an interaction, a value that could be important for many risk assessment applications. To accomplish this, they fitted an interaction equation to the growth inhibition data for each dose combination with a nonlinear regression technique that enabled the estimation of an interaction parameter α along with its standard error. The no-interaction hypothesis (Loewe additivity) would be rejected if the 95% confidence interval for the interaction term α did not include zero. The magnitude of α is directly related to the intensity of the interaction and to the degree of bowing of the isobole. Positive values of α indicate synergy, whereas negative values of α indicate antagonism.
Although the Levasseur study on paclitaxel and cisplatin was conducted in vitro with no corroborating results in vivo, we consider it to have been conducted at a relevant level of biological organization (Criterion 5). In this instance, in vitro results
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4/13/01, 2:31 PM 277 alone are readily interpretable because the goal of the study was to investigate potential cellular mechanisms underlying the enhanced clinical efficacy of combination therapy in cancer patients. The authors discuss that explanations based on pharmacokinetic alterations, cell cycle dependent toxicity, or pharmacodynamic mechanisms cannot account for the efficacy of combination treatment. Therefore, it was reasonable to investigate interactive effects at the cellular level in an attempt to better explain the clinical efficacy and hopefully to optimize the therapeutic regimen.
Levasseur and colleagues found qualitatively different types of interactions at different dose combinations of paclitaxel and cisplatin (Levasseur et al. 1997) . For example, in A121 cells, only one treatment schedule produced a consistent interaction -antagonism -for all effect levels at all dose combinations tested ( Figure 8a in the published study). Other treatment schedules produced synergy, antagonism or no-interaction at a particular effect level depending upon the binary dose combination (Figure 8b and Figures 9a-c in the published study). For A121 cells treated for 24 hours with paclitaxel prior to 4 hours of treatment with cisplatin, dose combinations yielded unambiguous synergy only for the higher effect levels. Isoboles for the IC50 and below showed complex response surfaces with localized regions of synergy and antagonism. The dose combination-dependence of these observed interactions underscores the necessity of assessing more than one ratio of the mixture components -in this case, five fixed mixtures were used -over a range of concentrations (Criterion 3).
Overall, the authors characterized their results as generally supporting the nointeraction hypothesis. It is important to understand that such a global characterization is possible and defensible only if a sufficient number of dose combinations are tested. Studies that do not incorporate such rigor cannot reliably support generalized statements about interactions between chemicals. The rigor of testing numerous dose combinations of paclitaxel and cisplatin at the cellular level allowed Levasseur and colleagues to draw reliable conclusions regarding potential mechanisms underlying the good clinical efficacy of combination therapy. Given the lack of consistent synergism at the cellular level, the authors attributed the clinical efficacy of combination therapy to the non-overlapping spectrum of organ toxicity of the two agents. A high dosage of both drugs can be attained, and thus a high level of anti-tumor activity, without increasing organ toxicity in the patient.
Another interesting feature is that a high degree of experimental variability was noted for interactions between paclitaxel and cisplatin. Ten experiments were conducted using each drug combined with itself to serve as a negative control for the no-interaction hypothesis. For some of these "sham" dose combinations, inconsistent isoboles were produced, but these were attributable to dilution errors or to increased sensitivity of cells pre-treated with a first dose of the chemical at earlier time points in some treatment schedules. Otherwise, these negative control experiments confirmed the no-interaction hypothesis. In dose combination experiments with both drugs, however, the shapes of the isoboles often varied from experiment to experiment for some treatment schedules, despite the fact that the same techniques have been used to produce consistent isoboles for combinations of other anti-tumor drugs (Faessel et al. 1998; Gaumont et al. 1992; Greco et al. 1990 ). The variability in this set of experiments suggests that close attention must be paid to 200350 .pgs 4/13/01, 2:31 PM
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inter-experimental variability in interaction studies. Indeed, the authors use the variability in this set of results as an illustration of why caution should be exercised when interpreting interesting but unreplicated interactions (Levasseur et al. 1997) . They stress that for interaction studies, it is extremely important to replicate experiments a sufficient number of times to be certain that the interactive effects are observed consistently.
Taylor et al. (1995)
Our third example that satisfies all five criteria is a study by Taylor and co-workers that tested the assumption of additivity for binary combinations of mutagens. The literature prior to this study was contradictory as to the mutagenicity of binary mixtures, with superadditivity (synergy), additivity, and subadditivity (antagonism) being reported (Albertini and Gocke 1992; Crebelli et al. 1991; Hass et al. 1987; Hermann 1981; Kaden et al. 1979; Kawalek and Andrews 1981; Ogawa et al. 1985 Ogawa et al. , 1987 Salamone et al. 1979; Somani et al. 1981; Thornton-Manning et al. 1989; Whong et al. 1989; Yoshida et al. 1979) . These complex responses were dependent on the dose combination tested. The majority of interactions reported in these studies were non-additive responses, with superadditivity (synergy ) being reported most frequently. In addition, few studies tested interactions between two mutagens. Instead, interactions between a mutagen and a comutagen were tested (Taylor et al. 1995) . A comutagen is a non-mutagenic chemical that enhances or inhibits the activity of a mutagen. Taylor and co-workers sought to extend the body of literature on the mutagenicity of binary combinations to include binary combinations of known mutagens and to evaluate relevant mutagenic environmental mixtures. They tested mutagenicity with and without metabolic activation with a standard S9 liver fraction.
Taylor and co-authors (Taylor et al. 1995) use the term "mixture" to refer to an entity found in the environment that consists of many different chemicals. They did not attempt to assess interactions between the components of complex mixtures, but instead tested mixtures as single entities and in binary combination with single chemicals. Single chemicals were selected on the basis of representing chemical classes known to be responsible for much of the mutagenic activity of the complex environmental mixtures. To test interactions between direct-acting mutagens, an organic extract of diesel exhaust was tested in the absence of S9, as was 1-nitropyrene, which contributes a significant fraction of the mutagenic activity of diesel exhaust. A chlorinated furanone found in some chlorinated drinking water supplies was also tested without metabolic activation. To test interactions between indirect-acting mutagens, an organic extract of combusted polyethylene and one of its constituents, benzo(a)pyrene, were tested with S9 metabolic activation, as was 4-aminobiphenyl, a compound found in cigarette smoke. By testing these single compounds alone and in binary combinations with the complex mixture, Taylor et al. obtained information about potential interactions between the single mutagenic components and the rest of the mixtures.
In preliminary experiments, Taylor et al. (1995) used seven doses to define the DRC for each agent individually (meets Criterion 1). Based on the resulting individual curves, doses were selected for the binary studies that fulfilled three conditions. The doses selected produced at least a twofold increase in mutant yield when 200350 .pgs 4/13/01, 2:31 PM 279 used individually. The doses selected were within the linear region of the DRC. The sum of the response for any two doses of different agents would not exceed 300 revertants per plate. Four or five doses were selected for testing individually and in combination. These conditions meet the requirements of Criterion 3 that different ratios of the mixture components be assessed across a sufficient concentration range. These conditions also form a defensible basis for selecting a model of noninteraction for testing the no-interaction hypothesis (satisfies Criterion 2). A statistical analysis of responses for dose combinations in the linear range of the DRCs was employed that is equivalent to testing the Loewe non-interaction hypothesis.
Models were fitted to the mutagenic responses at all doses of a given pair of chemicals, both alone and in combination. The model's fit included an interaction term that quantified the deviation from a purely additive response, thus allowing a statistical test to be applied to the non-interaction model (Taylor et al. 1995) . The no-interaction hypothesis (Criterion 2) for the data was tested using the Wald test statistic (meets Criterion 4). The direction of departure from non-interaction, i.e., synergy versus antagonism, was determined according to whether the value of the interaction term was less than or greater than zero.
Mutagenicity is a toxicological effect that requires evaluation at the molecular level of biological organization. This is because the expression of mutation at the level of the whole organism is sometimes ambiguous as to the underlying toxic effect. The standard method for assessing mutagenic potential is the Salmonella typphimurium (Ames) assay. Although there are ways to assess mutagenicity using whole organisms, the Ames assay uses fewer resources and time. The Ames assay has been used extensively for more than 4 decades and the limitations of its predictivity and relevance for mutagenicity and carcinogenicity in mammals has been well characterized (Ashby and Tennant 1988; Tennant et al. 1987) . Because the Salmonella assay is required for safety assessment under several regulatory programs (e.g., those pursuant to FIFRA, FFDCA), it is a reasonable goal to understand how mixtures behave in this assay. Because of those factors and its stated goals, the Taylor et al. study meets the criterion for assessment of interactions at a relevant level of biological organization (Criterion 5).
According to the literature on mutagenic activity of mixtures published prior to the Taylor study, non-interaction (additivity) has generally been observed at lower doses of mutagens, whereas the interactions observed were generally at higher doses. Synergy is reported to occur more frequently than antagonism. In agreement with previous literature, Taylor and co-workers found that combination responses were generally additive at low doses and interactive at high doses. Rather than a uniform interaction, they observed regions of local synergy and antagonism in the combination responses. In contrast to previous reports, however, they observed antagonism more frequently than synergism at higher doses, and this was true especially for combinations of indirect-acting mutagens. One possibility for this difference might be that other studies used different concepts of non-interaction for the no-interaction hypothesis. Other possibilities, of course, include the fact that Taylor and co-workers tested binary combinations of mutagens rather than mutagens in combination with comutagens, as did most of the prior studies. Taylor et al. conclude that collectively, the literature supports additivity as a reasonable 200350 .pgs 4/13/01, 2:31 PMassumption for binary combinations of relatively low doses of mutagens, but that additivity is less applicable to binary combinations of mutagens at high doses.
It is important to realize that Taylor and co-workers were able to draw meaningful conclusions about the utility of these assays to test the effects of mixtures against those of single compounds because the study design was appropriate for the goals of the study. Had the study not met the Criteria 1 through 4, it would have been impossible to determine if either assay actually detected interactions between known mutagenic agents in mixtures. The relevance and limitations of the Salmonella assay for predicting mutagenicity have been established, hence the biological level used to assess mutagenicity was relevant (satisfies Criterion 5). Meeting these conditions also allowed the comparison of two forms of the assay for their utility in studying interactions.
The preceding examples (Kissin et al. 1987; Levasseur et al. 1997; Taylor et al. 1995) illustrate that the five criteria provide a means of consistently evaluating studies that differ in goals, study designs, and methods of analyzing interactive effects. Despite such differences, the criteria can be applied equally to each study and help reveal that all three were conducted by established methods sufficiently thorough to yield reliable results. The results and conclusions of these studies are of sufficient quality to be used in lieu of default assumptions regarding the expected toxic effect of chemical mixtures. However, before applying the results of an interaction study to a particular risk assessment, a risk assessor should also consider the relevance of the conditions and doses used in a study to the exposure scenarios in question. Interactions that occur at high doses may not be manifested at the low environmental contaminant levels that many risk assessments must consider (Jonker et al. 1990 (Jonker et al. , 1993 Jonker et al. 1996; Seed et al. 1995) .
B. Using the Criteria to Weight the Quality of Contradictory Data
Risk assessors may often be faced with published studies that reach contradictory conclusions regarding the type of chemical interaction exhibited by two or more chemicals for a particular response. The following two studies investigate interactions between insect pheromones and structurally related synthetic analogs. An evaluation of these two studies illustrates how the criteria can assist in weighting contradictory results in order to choose the best model for combined action of the chemicals when present in mixtures (see Table 1 ). A comparison of these studies also illustrates why the fifth criterion is essential to reliable interaction analysis.
Synergistic Pheromone Analogs Burger et al. (1990)
Mayer and Doolittle (1995)
Female moths emit chemical sex signals, called sex pheromones, which are detected by olfactory specialist neurons housed within characteristic, often sexually dimorphic, sensilla located on the antenna of male moths. These antennal neurons are specialized to detect primarily one constituent of the female signal at low airborne concentrations. At elevated concentrations, however, the neurons will 200350 .pgs 4/13/01, 2:31 PM 281 respond to other compounds. Stimulation of the specialized neuron by female sex pheromone induces male moths to fly upwind in search of the emitting female. A male navigates toward a female by continuously redirecting his flight path -right or left -according to the antennal specialized neuron that is more highly stimulated. When both specialized neurons are maximally stimulated, the male stops his upwind flight in anticipation of finding the female nearby.
In 1990, Burger and co-workers (Burger et al. 1990 ) reported that 7-vinyldecyl acetate (7-VD), an analog of the female pheromone of false codling moths, Crytophlebia leucotreta (Meyrick), reduced field trap captures of males when incorporated into otherwise effective sex pheromone bait. These researchers found that while 370 males were captured at traps containing only a virgin female moth, no males were captured at traps that included both a female moth and a dispenser containing 2 µL of 7-VD. The authors concluded that 7-VD was a pheromone inhibitor.
Because it is technically unfeasible to measure levels of airborne sex pheromones in the field, Burger and co-workers did not determine the levels of the natural pheromone or synthetic analog emitted from traps. Neither did they measure concentrations that reached male moths at distances away from traps. It was thus impossible for Burger and colleagues to compare the responses produced by specific doses of individual compounds with those of specific combinations. Although somewhat implied by their report, Burger and co-authors did not use the term "antagonism" to characterize the effect of the analog, but instead refer to "inhibitory" pheromonal effects.
Based on the structural relationship of 7-VD to one of the two false codling moth pheromone components, Mayer and Doolittle (1995) undertook the synthesis of analogs that would have a structurally similar relationship to the sex pheromone (Z)-7-dodecenyl acetate (Z7-12:Ac) of the cabbage looper Trichoplusia ni (Hübner). They compared both the behavioral and neurophysiological effects of the analogs 6-vinlyldecyl acetate (6-VD) and 10-vinyltetradecyl acetate (10-VD) alone and binary mixtures with Z7-12:Ac. Action potentials were recorded from specialist neurons within individual antennal sensilla exposed to carefully controlled airborne concentrations of the compounds and mixtures. Binary mixtures of Z7-12:Ac and the analogs produced a response greater than the sum of the responses produced by the individual stimuli alone. In contrast with the inhibitory effect on male trapping observed in the field by Burger and co-workers, neither of the analogs inhibited the neurostimulatory effect of the pheromone component Z7-12:Ac. Normally effective concentrations of Z7-12:Ac in combination with analogs produced supra-maximal stimulation of the specialist neuron.
Mayer and Doolittle extended their electrophysiological studies by conducting combination studies on live male cabbage loopers in a wind tunnel. Consistent with the results of the electrophysiological studies, concentrations of pheromone that were incapable of eliciting an upwind flight and mating response in males when tested alone produced a marked increase in upwind flight and mating behavior when present in combination with the analogues. These results confirm that in addition to producing a synergistic electrophysiological response at the specialized neuron, the particular pheromone analogs tested were able to elicit synergistic responses of the relevant behavioral endpoints in individual male moths. In combination with optimally effective levels of pheromone, flight response was inhibited by the analogs.
The corroboration of results at the level of the neuron with behavioral responses elicited in the organism not only confirm that the synergism has molecular, physiological, and organismal relevance, but may also help to explain why Burger and coworkers observed an inhibition of the pheromone behavioral response in the field. Rather than a pharmacological antagonism at the molecular level, inhibition of the pheromone behavioral response in the wind tunnel and in the field would appear to be due to synergistic overstimulation of the specialized receptor neuron. At supramaximal stimulation of specialized neurons, males may not be induced to fly toward the emitting female because they perceive that the female is already in close proximity due to the intensity of the pheromone stimulus. If flight is initiated, successful navigation may be impossible because the difference in stimulation level between the two antennae necessary for directed flight would be overcome at distances far from the emitting female. The physiological and behavioral consequences of supra-maximal stimulation of the specialist neuron are consistent with these explanations.
Despite testing the effects of 7-VD on the population response of interest, Burger and co-workers (Burger et al. 1990) were unable to interpret the interaction of the analog with natural pheromone. The response observed in the field could have occurred by either antagonism or synergism of pheromone action (Criterion 5). Burger and colleagues were unable to test the individual agents (Criterion 1) or combinations of the agents (Criterion 3) across an appropriate dose range in field population studies, a limitation that further constrained their ability to distinguish the type of interaction responsible for the effect. They neither defined a no-interaction hypothesis (Criterion 2) nor tested observed results statistically against those predicted by a model of non-interaction (Criterion 4). Thus, the Burger et al. (1990) study does not satisfy any of the criteria proposed here (Table 1 summarizes the evaluation).
In their own combination experiments with pheromones and analogs, Mayer and Doolittle (1995) did not test a broad range of dose combinations (Criterion 3). They did, however, use estimated DRCs to choose effective and sub-effective concentrations of Z7-12:Ac, the natural pheromone. One of the analogs (6-VD) was tested at four airborne concentrations ranging from 2 × 10 -12 M to 1 × 10 -10 M, and the second analog (10-VD) at two concentrations, 3 × 10 -13 and 3 × 10 -12 M. These concentrations of the analogs were tested alone or in combination with two concentrations of Z7-12:Ac (1.9 × 10 -13 and 2.1 × 10 -11 M), the lower representing a subeffective concentration and the higher an effective concentration. This satisfies Criteria 1 and 3 because the goals of the study were to investigate the possibility that inhibition of pheromone activity was a likely explanation for the effect of the pheromone analog on male moths in the field, as reported by Burger. Mayer and Doolittle also specifically defined synergism, and in so doing, defined a no-interaction hypothesis (Criterion 2) based on effect summation. The authors state:
Synergism, in the sense that we use it for these studies, is the resultant response of the specialist neuron to the cooperative action of two or more discrete chemicals that is greater than the sum of the responses to the individual compounds.
There is debate regarding whether Loewe additivity, Bliss independence, or models based on slopes of DRCs are the most appropriate for receptor-mediated, graded 200350 .pgs 4/13/01, 2:31 PM 283 responses (Poch et al. 1995b; Scaramellini et al. 1997) . However, Mayer and Doolittle's no-interaction hypothesis -"the sum of the responses to the individual compounds" -is not equivalent to Loewe additivity because the dose response curves are not linear. Neither is it a statement of Bliss Independence, but the authors have provided no other appropriate non-interaction model (fails Criterion 2).
We estimated the expected responses under Loewe additivity and our results agree with the authors' conclusions (see Tables 1 and 2 ). We note, however, that our results cannot confirm the study's conclusions because they are not based on a statistical test between the predicted and observed responses, which would require data on the individual measurements.
We also inspected the data of Mayer and Doolittle (1995) by the isobolographic technique (see Figures 2 and 3 for a discussion of isobolograms), which is based on the Loewe additivity model of non-interaction. Figures 4a through 4e show isobolograms at various response levels estimated from a point-to-point linear interpolation of the dose-response data for electrophysiological responses of Z7-12:Ac, 6-VD and their binary combinations. These isobolograms show that estimated isoeffective dose combinations fall below the line of additivity estimated from the dose-response data for the agents alone. Numbers printed beside the points indicate combination index values (Berenbaum 1978 (Berenbaum , 1981 . The combination index is a calculation of the degree of departure from the line of additivity, which is the straight line between isoeffective doses of the individual agents plotted on either axis of the graph. Mathematically, the combination index is defined as CI = d a /D a + d b /D b , where D indicate individual doses of agents a and b isoeffective with dose combinations of the combination ab. If the combination index is significantly less than 1, the dose combination is synergistic; if the combination index is significantly greater than 1, the dose combination is antagonistic. These plots provide a visual estimate of the degree of synergy suggested by the published data of Mayer and Doolittle (1995) . Although lacking here, a statistical test should be applied to determine whether the confidence intervals for dose combinations overlap the confidence interval around the line of additivity (Gennings et al. 1990) .
Mayer and Doolittle (1995) used a probit analysis to distinguish differences between treated and control groups in their behavioral studies in the wind tunnel. They did not apply a statistical analysis to confirm differences between observed and expected effects in electrophysiological studies (fails Criterion 4), although they do report standard errors for their measurements. They should have made statistical comparisons between the measured response and the estimated expected response (Loewe additivity) taking account of all statistical variation in the measurements and estimates.
Application of the criteria (see Table 1 ) shows that the Mayer and Doolittle (1995) study is a more reliable test of chemical interactions than the study by Burger and colleagues (Burger et al. 1990 ). Mayer and Doolittle satisfied Criteria 1, 3, and 5, whereas Burger and co-workers did not satisfy any of the five criteria. This analysis illustrates how the five criteria can be used to weight studies that come to different conclusions regarding chemical interactions, or to weight the evidence for interactive toxicity reported for different chemical mixtures. Use of these criteria to weight Arnold and co-workers investigated responses to combinations of steroidal estrogens, the endogenous estrogenic hormones in mammals and many other vertebrates. Receptor-level interactions were evaluated using an in vitro transcriptional activation system in yeast consisting of the human estrogen receptor linked to a β-galactosidase reporter gene. Activation of the human estrogen receptor is measured in this system by the activity of β-galactosidase in the growth medium. Interaction of steroidal estrogens was also evaluated in vivo using temperature-dependent sex determination in red-eared slider turtles as a model system. Synergistic sex reversal by combinations of polychlorinated biphenyls has previously been reported in this species , and the results are discussed later in this paper.
A thorough discussion of the Arnold et al. study (Arnold et al. 1997a ) is important because it demonstrates how applying the criteria helps to identify inadequacies in data interpretation and study design critical to evaluating interaction studies (see Table 1 for a summary of the evaluation). For transcriptional activation experiments in yeast, Arnold et al. (1997a) did not explicitly define a no-interaction hypothesis, but compared the arithmetic sum of enzyme activity produced by doses of the agents alone with enzyme activity elicited by the same concentrations in combination (Criterion 2). However, a simple summation function is not consistent with the Bliss independence model, and in this situation is not consistent with the Loewe additivity model because the individual DRCs are not linear in the range used for the interaction analysis. The authors do not specify any other no-interaction hypothesis. Therefore, the study failed to test an appropriate no-interaction hypothesis (fails Criterion 2). Arnold et al. (1997a) used a full-factorial design to test multiple dose combinations based on the doses used to characterize the DRCs of the individual agents (Arnold et al. 1997a) . DRCs were determined for estradiol-17β, estrone, estradiol-17α, and estriol, but it is unclear whether the largest dose of any of the steroids elicited the maximum transcription activation levels in yeast (partially satisfies Criterion 1). However, since the dose combinations are within the same range as the doses of individual agents tested, the study satisfies Criterion 3 if the no-interaction hypothesis is response addition. Synergism was reported for the following combinations at submaximal response levels: estradiol-17β plus estrone; estradiol-17α plus estrone; estradiol-17α plus estradiol-17β, but not for dose combinations in the maximal response range for the individual estrogens.
The authors discuss that at high response levels dose combinations were not synergistic due to saturation of the receptor-mediated response (Arnold et al. 200350 .pgs 4/13/01, 2:32 PM 291 1997a). If one assumes that maximum enzyme activity was elicited by the largest dose combinations of estradiol-17-β and estrone tested, then these combinations might be regarded as purely additive because further increases in dose could elicit no greater response. However, because Arnold et al. did not sufficiently characterize the maximal enzyme induction (i.e., saturation) for the individual agents, there is considerable uncertainty in such conclusions. There is a second way to interpret the responses at high doses that is more consistent with the no-interaction hypotheses that was apparently understood by the authors (response-addition). If the DRC is truly linear and no maximum receptor mediated response is identified, then responses at high doses should be viewed as antagonistic.
In their yeast study, Arnold et al. (1997a) used a one-way analysis of variance least significant differences test, but it is unclear how this test was applied and whether results obtained with dose combinations were compared statistically with results expected under response addition. Even if the test was applied correctly (i.e., Criterion 4 was satisfied), no inferences can be made about interactions because the no-interaction hypothesis was deficient (Criterion 2 was failed). The raw data from the study would have to be reanalyzed using a valid non-interaction model and appropriate statistical test to determine whether conclusions can be made on a local or global basis.
Had Arnold et al. (1997a) used only an in vitro system to assess potential interactions, without attempting to verify the interactions in an organism, the study would clearly have failed the requirements of Criterion 5. While transcriptional activation assays may be more relevant to estrogenic activity in an organism than simple equilibrium binding displacement assays, interaction studies in transcriptional activation systems alone can only suggest potential interactions that may or may not manifest changes in vivo (McInnes and Brodie 1988) . To evaluate interactions in vivo, Arnold and co-workers also investigated the ability of combinations of steroidal estrogens to cause sex reversal in red-eared slider turtles (Arnold et al. 1997a) .
In the laboratory, the temperature at which eggs are incubated during the critical period of gonadal differentiation may influence sex determination in turtles. Turtle eggs were incubated at a male-producing temperature and treated with estradiol-17α, estradiol-17β, or estriol at the beginning of the period of gonadal differentiation during which the eggs are sensitive to the effects of estradiol-17β. The sex ratio at hatch was determined for only three doses of estriol and estradiol-17β individually (Criterion 1) and for only three dose combinations of estradiol-17β given in combination with 0.01 µg of estriol (Criterion 3). The dose response relationship on sex ratio was determined using polynomial logistic regression (Arnold et al. 1997a) .
This portion of the Arnold study satisfies Criteria 1 and 3 in that the DRCs for the individual agents were characterized sufficiently to see that they are linear in the range of the doses tested (i.e., logit of sex change proportion versus dose was linear). 5 The logit fit to the combination included a quadratic term to represent the flat response beginning at about 0.2 µg. The authors employed a one-tailed t-test to show that the linear term in the DRC for estradiol-17β alone was statistically smaller than the linear term in the DRC for the combination (Arnold et al. 1997a ). This finding was used to infer synergy for the combination. The authors did not determine the expected response under Loewe additivity or independence (fails Crite-Evaluative Criteria for Interaction Studies rion 2); therefore, their statistical test for synergy and their conclusion that the agents have a synergistic effect on sex reversal are questionable (fails Criterion 4).
While using both in vivo as well as in vitro approaches to assess interactions is preferable in this instance, it is not clear that interactions in a human estrogen receptor-reporter gene construct in yeast have any relevance to interactions in turtles. Hence, that combination of in vivo and in vitro studies would not fulfill the requirements of Criterion 5 to assess interactions at relevant levels of biological organization. Although we have not evaluated the reliability of the data, synergism between temperature and estradiol has been reported Wibbels et al. 1991a Wibbels et al. , 1991b . Hormone-temperature interactions, if they occur, could confound interactive effects of steroid hormones. Because it may be necessary to understand interactions between individual sex hormones and temperature before interactions between different sex hormones or chemicals are interpretable in the turtle egg system, the in vivo portion of the Arnold et al. study is also questionable for satisfying Criterion 5. The level of uncertainty introduced would have to be carefully considered before using the Arnold et al. (1997a) study in lieu of default non-interaction assumptions for mixture risk assessment. The study fails two of the five criteria and only partially satisfies others (see Table 1 for a summary of the evaluation).
D. Toward Improving Reliability Bergeron et al. (1994)
Kortenkamp and Altenburger (1998)
The following discussion of the Bergeron et al. (1994) study and Kortenkamp and Altenburger's (1998) reanalysis of the Bergeron study using isobols underscores the reasons that a clear and consistent method of evaluating interaction studies is needed. In their review, Kortenkamp and Altenburger (1998) present a clear discussion of how the recent debate over synergistic estrogenic effects has failed to take into account well-developed methods of interaction analysis developed over the last 100 years. Specifically, the authors highlight the need to characterize DRCs of the individual agents tested, the need to define the expected response assuming that chemicals do not interact, and the need to apply a valid statistical test to determine differences between observed effects and expected effects (criteria 1, 2, and 4). These authors also mention that testing dose combinations using multiple fixed mixtures is desirable (Criterion 3). Despite agreeing on the importance of certain aspects of interaction analysis, we differ with Kortenkamp and Altenburger (1998) regarding their acceptance of Bergeron and co-workers' conclusions. Accepting Bergeron's conclusions would appear to us to contradict the importance of the concepts and methods Kortenkamp and Altenburger (1998) explain so clearly.
The Bergeron et al. (1994) report was one of the earliest studies suggesting a synergistic estrogenic response. These authors reported a synergistic interaction between two hydroxylated polychlorinated biphenyls in producing sex reversal during development in the red-eared slider turtle. Bergeron and co-workers reached their synergy conclusion without explicit discussion of any of the issues addressed by the five criteria. Of more importance, the substance of their study fails four of the five criteria proposed here for evaluating interaction studies (see Table 1 ).
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Bergeron and co-workers' characterization of the DRCs for the individual PCBs are inadequate (Criterion 1), and a no-interaction hypothesis is not defined or tested (Criterion 2). Their conclusion that the components synergized is based on a single fixed mixture of the chemicals administered at only two doses, an insufficient amount of data on combination responses to characterize interactions generally (Criterion 3). Statistical tests to distinguish departure from additivity or independence were not applied (Criterion 4). Had the study design and data interpretation been adequate, the level of biological organization assessed may have provided a relevant basis for the conclusions had the relevance of the fixed-temperature model been established (fails Criterion 5).
To elaborate, Bergeron et al. (1994) used only two doses to characterize the DRCs of the individual PCBs (fails Criterion 1). They tested only two concentrations of the mixture, and both of these were at a 1:1 ratio of the components (fails Criterion 3). For 2′,4′,6′-trichloro-4-biphenylol, 100 µg produced sex reversal in 21% of eggs spotted with the substance, while 200 µg produced sex reversal in 100% of the treated eggs. For 2′,3′,4′,5′-tetrachloro-4-biphenylol, 100 µg produced less than 10% sex reversal and 200 µg produced approximately 26% sex reversal. The two agents were said to produce a synergistic interaction based on the observation that 10 µg of each in combination produced approximately 33% sex reversal. Bergeron et al. (1994) made no effort to distinguish their result statistically (fails Criterion 4) from a model of non-interaction (fails Criterion 2). They did not account for measurement variability and ignored DRC estimation uncertainty. Kortenkamp and Altenburger (1998) plotted an isobologram of the data by assuming the rough equivalence of the 21%, 26%, and 33% responses. Their isobologram shows that the 10 µg dose combination of each agent that produced 33% sex reversal falls below the additivity isobole for individual PCB doses of 100 µg and 200 µg (21% and 26% sex reversal), i.e., the combination is synergistic by their reanalysis. Based on their isobolographic reanalysis, Kortenkamp and Altenburger (1998) make a determination opposite ours regarding the reliability of Bergeron et al.' We find Kortenkamp and Altenburger's approach to be a constructive application of the local assessment of additivity using limited data. However, claiming that this approach validates Bergeron's conclusions works against their convincing discussion of the importance of applying concepts and methods of interaction analysis developed over the past 100 years in the fields of pharmacology, toxicology, ecotoxicology, epidemiology, chemotherapy, and biometry (Kortenkamp and 200350.pgs 4/13/01, 2:32 PM 294
Altenburger 1998; concepts addressed by Criteria 1 and 4). In contrast to basing their determination on a reasonable characterization of the DRCs of the agents alone, their determination requires the assumption of a monotonically increasing DRC for sex reversal by the individual PCBs. Their determination was also made in the absence of statistical tests.
Based on the published data, the behavior of the individual DRCs below 100 µg is unknown. Doses less than 100 µg were not tested for the PCBs individually. Thus, no information is provided about the slope of the individual DRCs in the range at which combination responses were assessed. Although we agree that many reasonable extrapolations of the DRCs back to 10 µg or back to 0 µg would support a finding of synergy, there also exist extrapolations of the DRCs that would not support synergy. Without additional data at lower doses, the characteristics of the DRCs (Criterion 1) and subsequent analyses of additivity are speculative.
Therefore, we hesitate to agree with Kortenkamp and Altenburger's (1998) acceptance of Bergeron et al. (1994) conclusions because the study lacks sufficient rigor to infer interactions. Bergeron et al. (1994) may have correctly identified a synergistic effect, but their conclusions cannot be accepted as valid without assuming both the shape of the individual and combination DRCs and the results of statistical analyses. It is noteworthy that a more recent publication by Bergeron et al. (1999) indicates that 12 of 14 binary dose combinations of steroidal estrogens were additive, only two dose combinations were synergistic, and that all three ternary dose combinations tested were additive.
IV. CONCLUDING REMARKS
Mixture risk assessments will generally be more accurate when the underlying studies are scientifically rigorous and match the goals of the risk assessment. However, studies that rely on assumptions rather than accepted principles of interaction analysis are widespread in the toxicological and pharmacological literature, as has been discussed by others (Berenbaum 1989; USEPA 1990 ) and illustrated by several of the studies analyzed in this paper. In contrast, reliable interaction studies are those that are interpretable without making assumptions about untested and unanalyzed parameters. Although there is debate among experts regarding which models of non-interaction, which methods of combination analysis, and which statistical tests are most appropriate, these unresolved scientific questions should not prevent adherence to accepted principles of interaction analysis. Accepted principles of analysis must be clear so that risk assessors and researchers can apply the science in a way that best supports the needs of risk assessment.
In this paper, we propose a set of five criteria to be used as a guideline for evaluating studies of chemical interactions. In Section II, we attempted to demonstrate that the criteria are grounded in accepted principles of interaction analysis that reflect the consensus of the literature developed over decades of research in pharmacology, toxicology, and biometry. In Section III, we attempted to demonstrate how the criteria advance larger scientific goals. The three examples presented in Section IIIA (Kissin et al. 1987; Levassuer et al. 1997; Taylor et al. 1995) addressed how the five criteria allow a consistent and objective evaluation of interaction studies that differ in goals, design, and methodology. Without such a guideline, the reliabil-
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4/13/01, 2:32 PM 295 ity of such divergent studies for drawing conclusions, making predictions, and forming testable hypotheses might be less clear to a majority of risk assessors and researchers. By comparing the two studies in Section IIIB (Burger et al. 1990; Mayer and Doolittle et al. 1995) , we attempted to show how the criteria clarify differences between study designs and methods of analysis. Together with the discussion of studies in Sections IIIC and D (Arnold et al. 1997a; Bergeron et al. 1994; Kortencamp and Altenburger 1998) , we tried to demonstrate how the criteria help identify critical deficiencies that limit the inferences that can be drawn based on data. Through these examples, we also tried to show how the criteria help to clarify differences in the underlying assumptions and conclusions of different analysts, and how the criteria help to clarify uncertainties regarding interaction conclusions. We believe these examples also suggest how widespread application of these criteria would lead to more testable hypotheses and more consistent and reliable conclusions. The validity of the five criteria proposed in this paper depend on the extent to which they further such goals.
Although the five criteria proposed in this review are indeed prescriptive, there is wide latitude among the various methods and approaches that will satisfy them. Applying these criteria may assist risk assessors who must evaluate interaction studies for use in risk assessments of chemical mixtures by helping them to distinguish between sound, reliable studies and those for which the conclusions require an unacceptable number of assumptions. Application of the criteria would also allow refocusing the scientific discussion on how best to use interaction data in the toxicological assessment of chemical mixtures. Refocusing the discussion would encourage research aimed at improving risk and safety assessments for chemical mixtures found in products, food and the environment.
